These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1174 related items for PubMed ID: 17462500

  • 21. Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro.
    Miyazawa M, Iwahashi M, Ojima T, Katsuda M, Nakamura M, Nakamori M, Ueda K, Naka T, Hayata K, Iida T, Yamaue H.
    Cancer Lett; 2011 Jun 01; 305(1):32-9. PubMed ID: 21397388
    [Abstract] [Full Text] [Related]

  • 22. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
    Zhang HM, Zhang LW, Liu WC, Cheng J, Si XM, Ren J.
    Cytotherapy; 2006 Jun 01; 8(6):580-8. PubMed ID: 17148035
    [Abstract] [Full Text] [Related]

  • 23. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.
    Tamaki S, Homma S, Enomoto Y, Komita H, Zeniya M, Ohno T, Toda G.
    Clin Immunol; 2005 Dec 01; 117(3):280-93. PubMed ID: 16246626
    [Abstract] [Full Text] [Related]

  • 24. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.
    Pérez-Díez A, Butterfield LH, Li L, Chakraborty NG, Economou JS, Mukherji B.
    Cancer Res; 1998 Dec 01; 58(23):5305-9. PubMed ID: 9850054
    [Abstract] [Full Text] [Related]

  • 25. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ, Yao K, Yu CJ, Chen X, Lu MP, Sun H, Li BZ, Ding CN, Zhou F.
    Auris Nasus Larynx; 2006 Dec 01; 33(4):441-6. PubMed ID: 16934422
    [Abstract] [Full Text] [Related]

  • 26. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY, Wang L, Lu MD, Li BJ, Huang JF.
    Hepatogastroenterology; 2008 Dec 01; 55(81):155-9. PubMed ID: 18507097
    [Abstract] [Full Text] [Related]

  • 27. Elicitation of both CD4 and CD8 T-cell-mediated specific immune responses to HCA587 protein by autologous dendritic cells.
    Li B, He X, Pang X, Zhang H, Chen J, Chen W.
    Scand J Immunol; 2004 Nov 01; 60(5):506-13. PubMed ID: 15541044
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.
    Detournay O, Mazouz N, Goldman M, Toungouz M.
    Hum Immunol; 2005 May 01; 66(5):460-8. PubMed ID: 15935883
    [Abstract] [Full Text] [Related]

  • 30. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
    Dubsky P, Saito H, Leogier M, Dantin C, Connolly JE, Banchereau J, Palucka AK.
    Eur J Immunol; 2007 Jun 01; 37(6):1678-90. PubMed ID: 17492620
    [Abstract] [Full Text] [Related]

  • 31. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
    Radford KJ, Turtle CJ, Kassianos AJ, Hart DN.
    J Immunother; 2006 Jun 01; 29(6):596-605. PubMed ID: 17063122
    [Abstract] [Full Text] [Related]

  • 32. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro.
    Li YG, Wang ZP, Tian JQ, Tian BQ, Rodrigues R, Shang PF, Zhang T.
    Cancer Invest; 2009 Nov 01; 27(9):909-17. PubMed ID: 19832038
    [Abstract] [Full Text] [Related]

  • 33. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 01; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 34. [Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)].
    Guo J, Cai M, Wei D, Qin L, Huang J, Wang X.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun 01; 10(3):178-80. PubMed ID: 12113671
    [Abstract] [Full Text] [Related]

  • 35. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H.
    Int J Oncol; 2006 Sep 01; 29(3):531-9. PubMed ID: 16865268
    [Abstract] [Full Text] [Related]

  • 36. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J, Chen M, Peng ML, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar 01; 13(3):198-201. PubMed ID: 15760555
    [Abstract] [Full Text] [Related]

  • 37. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 38. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
    Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H, Storkus WJ.
    Cancer Res; 2003 Oct 01; 63(19):6378-86. PubMed ID: 14559827
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 01; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.